G. Lind-Albrecht

TL;DR: If FOI has the potential to be a sensitive and valuable tool for monitoring disease activity on site in clinical settings and for serving as an outcome parameter in clinical trials, it is suggested that it allows sensitive and reliable detection of inflammatory changes in early arthritis.

TL;DR: A higher burden of AS in female patients and less improvement in outcome measures compared with men, ‘despite women having a later disease onset and shorter disease duration’ is found.

TL;DR: The detection of typical inflammatory changes in subjects with cutaneous manifestations of PsA or family history of psoriasis and joint pain but without clinical signs of synovitis or tendinitis suggests that a non-arthritic, subclinical disease stage may precede the onset of clinically active PsA.

TL;DR: Extraarticular signal intensities in the hands of patients with clinically asymptomatic hand and finger joints probably represent subclinical disease activity and could play a role in early diagnosis and in the assessment of therapeutic response.